TCT 2022: Edwards' Pascal Matches Abbott's MitraClip In CLASP IID

 
• By Reed Miller

Results of the CLASP IID trial showed Edwards’ Pascal mitral valve repair system was non-inferior for safety and effectiveness compared to Abbott’s MitraClip device.

Edwards' Pascal Precision Transcatheter Valve Repair System
• Source: Edwards Lifesciences

More from Clinical Trials

More from R&D